Squarepoint’s Q32 Bio QTTB Stock Holding History

Squarepoint’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$303K	Buy	+23,790	New	+$199K	﹤0.01%	3798
2025 Q2	–	Sell	-14,528	Closed	-$24K	–	5172
2025 Q1	$24K	Sell	14,528 -4,481	-24%	-$12.1K	﹤0.01%	4424
2024 Q4	$65.4K	Buy	+19,009	New	+$600K	﹤0.01%	4796
2023 Q3	–	Sell	-567	Closed	-$9.03K	–	4334
2023 Q2	$9.03K	Buy	+567	New	+$10.2K	﹤0.01%	3498
2021 Q2	–	Sell	-1,056	Closed	-$179K	–	3771
2021 Q1	$179K	Buy	+1,056	New	+$222K	﹤0.01%	2742
2020 Q1	–	Sell	-1,631	Closed	-$608K	–	2629
2019 Q4	$608K	Buy	+1,631	New	+$467K	﹤0.01%	1651
2019 Q3	–	Sell	-611	Closed	-$215K	–	2725
2019 Q2	$215K	Buy	+611	New	+$240K	﹤0.01%	2083

Other funds holding QTTB

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Squarepoint's QTTB Position: Q2 2026 in Review

Squarepoint opened a new position in Q32 Bio (QTTB) in Q2 2026: 23,790 shares worth $303K. The stake represents ﹤0.01% of the portfolio and ranks #3798 among its holdings. This is a return to the name: Squarepoint previously reported a position in QTTB as recently as Q1 2025.

Squarepoint first reported a position in QTTB in Q2 2019 and has held it in 7 quarters since. The position peaked at $608K in Q4 2019. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

Squarepoint held 23,790 shares of Q32 Bio worth $303K as of Q2 2026.
Q32 Bio was a new Squarepoint position in Q2 2026.
Q32 Bio made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3798 holding.
Squarepoint first reported a position in Q32 Bio in Q2 2019 and has held it in 7 quarters since.
Squarepoint's Q32 Bio position peaked at $608K in Q4 2019.
72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.